Main Street Group’s Kura Oncology KURA Stock Holding History

Main Street Group’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50	Closed	-$1.06K	–	828
2024 Q2	$1.06K	Hold	50	–	–	﹤0.01%	761
2024 Q1	$1.09K	Buy	+50	New	+$972	﹤0.01%	788

Other funds holding KURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Main Street Group's KURA Position: Q3 2024 in Review

Main Street Group sold out of Kura Oncology (KURA) in Q3 2024, closing a stake of 50 shares — an estimated $1.06K sold.

Main Street Group first reported a position in KURA in Q1 2024 and held it in 2 quarters. The position peaked at $1.09K in Q1 2024. 179 funds tracked by Wall St. Rank hold KURA as of Q3 2024.

Main Street Group reported no remaining Kura Oncology position as of Q3 2024 after selling out during the quarter.
Main Street Group sold 50 Kura Oncology shares in Q3 2024, an estimated $1.06K.
Main Street Group first reported a position in Kura Oncology in Q1 2024 and held it in 2 quarters.
Main Street Group's Kura Oncology position peaked at $1.09K in Q1 2024.
179 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2024.

Based on Main Street Group's 13F filing for Q3 2024, filed 13 Nov 2024.